---
title: "Document: WuXi XDC holders seek to raise up to HKD 2.4 billion through block trades"
description: "The transaction terms indicate that WuXi XDC's holder, Huanquan Pharmaceutical Hong Kong Investment Co., Ltd., seeks to raise up to HKD 2.4 billion through block trades: issuing 30.3 million shares, p"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/260268080.md"
published_at: "2025-10-08T10:26:30.000Z"
---

# Document: WuXi XDC holders seek to raise up to HKD 2.4 billion through block trades

> The transaction terms indicate that WuXi XDC's holder, Huanquan Pharmaceutical Hong Kong Investment Co., Ltd., seeks to raise up to HKD 2.4 billion through block trades: issuing 30.3 million shares, priced at HKD 77 to HKD 79.07 per share, representing a discount of 4.5% to 7% compared to Wednesday's closing price of HKD 82.80, accounting for approximately 2.47% of the existing circulating shares, with a 90-day lock-up period for the seller, and Morgan Stanley serving as the exclusive bookrunner

The transaction terms indicate that WuXi XDC's holder, Huanquan Pharmaceutical Hong Kong Investment Co., Ltd., seeks to raise up to HKD 2.4 billion through a block trade: issuing 30.3 million shares, priced at HKD 77 to HKD 79.07 per share, representing a discount of 4.5% to 7% compared to Wednesday's closing price of HKD 82.80, accounting for approximately 2.47% of the existing shares outstanding, with a 90-day lock-up period for the seller, and Morgan Stanley serving as the exclusive bookrunner

### Related Stocks

- [02268.HK - WUXI XDC](https://longbridge.com/en/quote/02268.HK.md)
- [MS.US - Morgan Stanley](https://longbridge.com/en/quote/MS.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Nomura Adjusts WuXi XDC Cayman's Price Target to HK$87.73 From HK$82.72, Keeps at Buy | Nomura Adjusts WuXi XDC Cayman's Price Target to HK$87.73 From HK$82.72, Keeps at Buy | [Link](https://longbridge.com/en/news/275736820.md) |
| Morgan Stanley Decreases Total Voting Rights in flatexDEGIRO SE to 3.19% | Morgan Stanley has reduced its voting rights in flatexDEGIRO SE from 3.63% to 3.19%, a decrease of 0.44 percentage point | [Link](https://longbridge.com/en/news/275636914.md) |
| WuXi XDC Dispatches Offer Document for Cash Takeover of TOT BIOPHARM | WuXi XDC Cayman Inc. has sent out an offer document for a voluntary cash takeover of TOT BIOPHARM International Co. Ltd. | [Link](https://longbridge.com/en/news/275675866.md) |
| J.P. Morgan Appoints Geneva-Based Banker to International Senior Role | J.P. Morgan has appointed Burkhard Koep as the new Global Head of Communications Investment Banking, based in Geneva. Ko | [Link](https://longbridge.com/en/news/275729531.md) |
| Here's How Much $100 Invested In Morgan Stanley 5 Years Ago Would Be Worth Today | Morgan Stanley (NYSE:MS) has delivered an average annual return of 19.52% over the past 5 years, outperforming the marke | [Link](https://longbridge.com/en/news/274864800.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.